Home6541 • TPE
add
Tanvex Biopharma Inc
Previous close
$41.95
Day range
$41.45 - $42.35
Year range
$40.85 - $72.00
Market cap
11.01B TWD
Avg Volume
518.04K
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
| (TWD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 178.95M | 6,268.43% |
Operating expense | 129.86M | -53.44% |
Net income | -420.54M | -51.16% |
Net profit margin | -235.00 | 97.63% |
Earnings per share | — | — |
EBITDA | -146.58M | 41.41% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 878.71M | 133.10% |
Total assets | 7.96B | 191.07% |
Total liabilities | 2.27B | 23.09% |
Total equity | 5.69B | — |
Shares outstanding | 264.82M | — |
Price to book | 1.95 | — |
Return on assets | -11.58% | — |
Return on capital | -12.60% | — |
Cash Flow
Net change in cash
| (TWD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -420.54M | -51.16% |
Cash from operations | -166.26M | 41.46% |
Cash from investing | -341.52M | -922.33% |
Cash from financing | -11.72M | 81.22% |
Net change in cash | -514.34M | -40.86% |
Free cash flow | -495.76M | -104.46% |
About
Founded
2013
Website
Employees
201
